VistaGen Therapeutics (VTGN) Earnings Date, Estimates & Call Transcripts $2.00 +0.03 (+1.52%) As of 06/30/2025 04:00 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock VistaGen Therapeutics Earnings Summary VistaGen Therapeutics posted Q4 2025 earnings on June 17, 2025, reporting an EPS of -$0.43, which beat analysts' consensus estimates of -$0.52 by $0.09. Quarterly revenue was reported to be ($0.01) million, below analyst estimates of $0.18 million. With a trailing EPS of -$1.66, VistaGen Therapeutics' earnings are expected to grow next year, from ($1.77) to ($1.74) per share. Upcoming Q1 Earnings DateAug. 12Before Market OpensEstimatedConsensus EPS (Jun. 17) -$0.52 Actual EPS (Jun. 17) -$0.43 Beat By $0.09 Actual Revenue (Jun. 17) -$0.01MQ4 2025 Earnings ResourcesQ4 2025 Earnings ReportConference Call Transcript & Audio Annual Report (10-K) Press Release (8-K)VTGN Upcoming EarningsVistaGen Therapeutics' next earnings date is estimated for Tuesday, August 12, 2025, based on past reporting schedules. Powered by Get VistaGen Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on VistaGen Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataVTGN Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.VTGN Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. VistaGen Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.41-$0.41-$0.41Q2 20251-$0.39-$0.39-$0.39Q3 20251-$0.48-$0.48-$0.48Q4 20251-$0.57-$0.57-$0.57 FY 2025 4 -$1.85 -$1.85 -$1.85 Q1 20261-$0.44-$0.44-$0.44Q2 20261-$0.47-$0.47-$0.47Q3 20261-$0.24-$0.24-$0.24Q4 20261-$0.25-$0.25-$0.25 FY 2026 4 -$1.40 -$1.40 -$1.40 Q1 20271-$0.37-$0.37-$0.37Q2 20271-$0.43-$0.43-$0.43Q3 20271-$0.48-$0.48-$0.48Q4 20271-$0.41-$0.41-$0.41 VistaGen Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/12/2025(Estimated)--------6/17/2025Q4 2025-$0.52-$0.43+$0.09-$0.43$0.18M-$0.01M2/13/2025Q3 2025-$0.48-$0.46+$0.02-$0.46$0.18M$230.00B11/7/2024Q2 2025-$0.40-$0.42 -$0.02-$0.42$0.34M$0.18M8/13/2024Q1 2025-$0.41-$0.35+$0.06-$0.35$0.30M$0.08M6/11/2024Q4 2024-$0.34-$0.25+$0.09-$0.25$0.41M$0.20M2/13/2024Q3 2024-$0.31-$0.22+$0.09-$0.22$0.73M$0.41M11/9/2023Q2 2024--$0.66 -$0.66-$0.66-$0.28M8/10/2023Q1 2024--$0.94 -$0.94-$0.94-$0.18M VistaGen Therapeutics Earnings - Frequently Asked Questions When is VistaGen Therapeutics' earnings date? VistaGen Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 12th, 2025 based off last year's report dates. Learn more on VTGN's earnings history. Did VistaGen Therapeutics beat their earnings estimates last quarter? In the previous quarter, VistaGen Therapeutics (NASDAQ:VTGN) reported ($0.43) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.52) by $0.09. Learn more on analysts' earnings estimate vs. VTGN's actual earnings. How can I listen to VistaGen Therapeutics' earnings conference call? The conference call for VistaGen Therapeutics' latest earnings report can be listened to online. Listen to Conference Call How can I read VistaGen Therapeutics' conference call transcript? The conference call transcript for VistaGen Therapeutics' latest earnings report can be read online. Read Transcript How much revenue does VistaGen Therapeutics generate each year? VistaGen Therapeutics (NASDAQ:VTGN) has a recorded annual revenue of $490,000.00. How much profit does VistaGen Therapeutics generate each year? VistaGen Therapeutics (NASDAQ:VTGN) has a recorded net income of -$51.42 million. VTGN has generated -$1.66 earnings per share over the last four quarters. What is VistaGen Therapeutics' EPS forecast for next year? VistaGen Therapeutics' earnings are expected to grow from ($1.77) per share to ($1.74) per share in the next year. More Earnings Resources from MarketBeat Related Companies Aurora Cannabis Earnings Date Acelyrin Earnings Date Canopy Growth Earnings Date biote Earnings Date Inhibrx Biosciences Earnings Date Design Therapeutics Earnings Date Esperion Therapeutics Earnings Date MediWound Earnings Date Cardiff Oncology Earnings Date I-Mab Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Smith & Wesson Stock Falls on Earnings Miss, Tariff WoesWhat to Expect From the Q2 Earnings Reporting CycleBroadcom Slides on Solid Earnings, AI Outlook Still StrongFive Below Pops on Strong Earnings, But Rally May StallRed Robin's Comeback: Q1 Earnings Spark Investor HopesOllie’s Q1 Earnings: The Good, the Bad, and What’s NextBroadcom Earnings Preview: AVGO Stock Near Record Highs This page (NASDAQ:VTGN) was last updated on 7/1/2025 by MarketBeat.com Staff From Our PartnersHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredNvidia’s Huang: AI is going to need 100x more power12Nvidia CEO Jensen Huang didn't mince words. After Nvidia's latest earnings call, Huang said AI now requires...Weiss Ratings | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredTrump Makes Major Crypto AnnouncementTrumps “Secret Weapon” for Crypto Dominance There's a growing push for America to lead the next wave of dig...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VistaGen Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share VistaGen Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VTGN Stock Alerts